Compare · ADGM vs MDLN
ADGM vs MDLN
Side-by-side comparison of Adagio Medical Holdings Inc (ADGM) and Medline Inc. (MDLN): market cap, price performance, sector, and recent activity on the wire.
Summary
- Both ADGM and MDLN operate in Medical/Dental Instruments (Health Care), so they compete in similar markets.
- MDLN is the larger of the two at $52.27B, about 4440.5x ADGM ($11.8M).
- Over the past year, ADGM is down 65.9% and MDLN is down 2.3% - MDLN leads by 63.6 points.
- MDLN has been more active in the news (4 items in the past 4 weeks vs 1 for ADGM).
- MDLN has more recent analyst coverage (25 ratings vs 2 for ADGM).
PerformanceADGM-56.81%MDLN-2.33%
2025-12-17+0.00%2026-07-17
- Company
- Adagio Medical Holdings Inc
- Medline Inc.
- Price
- $0.52-1.02%
- $39.80-3.23%
- Market cap
- $11.8M
- $52.27B
- 1M return
- -28.82%
- +7.36%
- 1Y return
- -65.93%
- -2.33%
- Industry
- Medical/Dental Instruments
- Medical/Dental Instruments
- Exchange
- NASDAQ
- NASDAQ
- IPO
- 2025
- News (4w)
- 1
- 4
- Recent ratings
- 2
- 25
Latest ADGM
- Amendment: SEC Form 10-K/A filed by Adagio Medical Holdings Inc
- Adagio Medical Holdings Inc filed SEC Form 8-K: Submission of Matters to a Vote of Security Holders
- Adagio Medical Holdings Inc filed SEC Form 8-K: Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing
- Adagio Medical Holdings Inc filed SEC Form 8-K: Other Events, Financial Statements and Exhibits
- Adagio Medical Submits Premarket Approval Application to FDA for vCLAS® Ventricular Ablation System for the Treatment of Ventricular Tachycardia
- Amendment: SEC Form SCHEDULE 13G/A filed by Adagio Medical Holdings Inc
- Amendment: SEC Form SCHEDULE 13G/A filed by Adagio Medical Holdings Inc
- SEC Form 10-Q filed by Adagio Medical Holdings Inc
- Adagio Medical Holdings Inc filed SEC Form 8-K: Results of Operations and Financial Condition, Financial Statements and Exhibits
- SEC Form DEF 14A filed by Adagio Medical Holdings Inc
Latest MDLN
- Medline Inc. filed SEC Form 8-K: Leadership Update
- Medline announces Prime Vendor agreement with Allina Health
- Securing new 1.6-plus million square feet of new space after fire, Medline leases two large distribution centers in Northern California
- Medline to report second quarter 2026 results on August 5, 2026
- Officer Abrams William J covered exercise/tax liability with 1,308 shares, decreasing direct ownership by 7% to 16,546 units (SEC Form 4)
- Chief Human Resources Officer Shryock Christopher P covered exercise/tax liability with 872 shares, decreasing direct ownership by 7% to 11,031 units (SEC Form 4)
- Chief Operating Officer Miller Stephen L covered exercise/tax liability with 1,889 shares, decreasing direct ownership by 7% to 23,899 units (SEC Form 4)
- Chief Legal Officer Liberman Alexander M. covered exercise/tax liability with 872 shares, decreasing direct ownership by 7% to 11,031 units (SEC Form 4)
- Chief Product Officer Laabs Amanda H. covered exercise/tax liability with 1,889 shares, decreasing direct ownership by 7% to 23,899 units (SEC Form 4)
- Chief Financial Officer Drazin Michael B covered exercise/tax liability with 1,889 shares, decreasing direct ownership by 7% to 23,899 units (SEC Form 4)